Racemic ketamine, esketamine, and arketamine are the three forms most often discussed in modern psychiatric care. This guide is part of Fountain Health ketamine education series, explaining the differences between various types and what they mean for patients.

When people search for the different types of ketamine, they are usually trying to answer two questions: What are the main forms of ketamine, and how do those differences matter in real medical care? In mental health settings, the most common terms you will see are racemic ketamine, esketamine or S-ketamine, and arketamine or R-ketamine. For patients, the important differences are not only chemical. They also involve how a treatment is delivered, what is FDA-approved, what is still being studied, and what type of medical supervision is required.

At Fountain Health NYC, we believe patients deserve clear, plain-language education before they make decisions about care. This guide is designed to help new patients in NYC understand the terminology, compare ketamine options responsibly, and know what questions to ask during a clinical evaluation.

The Three Main Types of Ketamine (Quick Overview)

In mental health discussions, three forms of ketamine are most commonly mentioned:

Racemic ketamine A mixture of two mirror-image molecules called R-ketamine and S-ketamine. It has long been used as an anesthetic and may be used off-label in some physician-supervised psychiatric settings.

Esketamine (S-ketamine)The S-ketamine isomer of ketamine. In the United States it is available as the prescription nasal spray Spravato, which has FDA-approved indications for certain depression-related conditions under supervised administration.

Arketamine (R-ketamine) The R-ketamine isomer. It is currently being studied in research settings and is not an FDA-approved psychiatric treatment in routine clinical practice.

These forms share a related chemical structure, but they differ in regulatory status, delivery methods, and how they are discussed in patient care today.

Ketamine isomers explained in plain language

An isomer is a molecule that has the same chemical formula as another molecule but is arranged differently. In the case of ketamine, the two forms are called R-ketamine and S-ketamine. You can think of them as closely related chemical mirror images.

When both are present together, that is called racemic ketamine. When only the S form is used, that is esketamine. When only the R form is discussed, that is arketamine. Research interest in these differences exists because the forms may behave somewhat differently in the body and brain, but the science is still evolving and should not be oversimplified into marketing claims.

What is racemic ketamine?

Racemic ketamine contains both R-ketamine and S-ketamine in equal parts. Ketamine has long been FDA-approved as an anesthetic, and in some psychiatric settings it may be used off-label under physician supervision. That is different from saying it is FDA-approved for depression, anxiety, PTSD, or other psychiatric conditions. It is not.

Racemic ketamine is often the form people mean when they talk about ketamine IV therapy or a ketamine infusion. The exact treatment plan, route, monitoring, and follow-up can vary by clinic and by patient, which is why evaluation matters.

What is esketamine?

Esketamine is the S-ketamine isomer. In the United States, esketamine is available as SPRAVATO, a prescription nasal spray with specific FDA-approved psychiatric indications and required supervised administration. FDA materials note that it must be dispensed and administered in certified health care settings with observation after dosing because of risks such as sedation, dissociation, respiratory depression, and misuse or abuse.

That means esketamine is not simply “the same thing” as any ketamine treatment you may read about online. It has its own product label, safety requirements, and delivery model. For patients, that distinction matters. You can read more in our glossary entry on Esketamine (Spravato).

What is arketamine?

Arketamine is the R-ketamine isomer. It is often discussed in academic and research conversations because scientists are interested in whether it may differ from S-ketamine in areas like antidepressant activity, tolerability, or duration of effect. But for patients seeking care today, the key point is simple: arketamine is still an emerging research topic, not a standard, widely established psychiatric treatment option in routine clinical practice.

That is why responsible patient education should mention arketamine without overstating its availability or suggesting that it is an established everyday choice.

Comparison table: Racemic ketamine vs esketamine vs arketamine

Types of Ketamine Explained: Racemic Ketamine vs Esketamine vs Arketamine

This chart is educational and not a recommendation for any one treatment path.

S-ketamine vs R-ketamine: what is the difference?

The difference between R-ketamine and S-ketamine starts at the molecular level. They are related forms of the same drug, but their structure is not identical. Researchers have studied whether those differences translate into differences in receptor activity, antidepressant response, side-effect profile, or how long effects may last.

Some studies and reviews suggest that racemic ketamine and esketamine may not perform identically across all outcomes. At the same time, evidence has limits, study designs differ, and patients should be careful not to treat early or mixed findings as settled clinical fact. The practical takeaway for most new patients is that the “best” choice cannot be decided by isomer language alone. It depends on diagnosis, history, goals, access, monitoring needs, and physician judgment.

The differences between esketamine nasal spray and IV ketamine therapy are discussed in greater detail in our article on Spravato vs IV ketamine.

Esketamine vs arketamine vs ketamine: what matters most for patients?

For a new patient, the biggest distinctions usually come down to five questions:

1. Is it FDA-approved for psychiatric use?

Esketamine nasal spray has specific FDA-approved psychiatric indications. Ketamine itself does not have FDA approval for psychiatric disorders, even though it may be used off-label in some clinical settings. Arketamine is still largely in the research conversation.

2. How is it given?

Different ketamine-related treatments may be discussed in terms of IV administration, intranasal administration, or other routes depending on the setting. Route affects onset, monitoring, logistics, and the overall treatment experience.

3. What kind of monitoring is required?

FDA materials for SPRAVATO describe supervised administration and observation after dosing in certified settings. More broadly, ketamine-related care should involve thoughtful screening, monitoring, and follow-up based on the patient’s medical and psychiatric profile.

4. What does the evidence actually support?

Some forms and delivery systems have more mature evidence or clearer regulatory pathways than others. Others remain promising but less established. That is one reason patient-first education should separate research interest from real-world availability.

5. How does it fit into a broader treatment plan?

A ketamine-related therapy should not be framed as a stand-alone magic fix. (This article explains Why Ketamine Therapy Sometimes Fails.) Clinical context matters. History, coexisting conditions, medications, risk factors, follow-up care, and integration into a broader treatment plan all affect whether a treatment is appropriate. Fountain discusses this structured approach in The Fountain Health 4-Phase Ketamine Therapy Framework.

Why route of administration matters as much as the molecule

Patients often focus on whether something is ketamine, esketamine, or arketamine. That is understandable, but the route of administration can matter just as much.

IV ketamine

When patients talk about IV ketamine, they are generally referring to physician-supervised administration of ketamine in an infusion setting. This route is often discussed in clinics that focus on precision, monitoring, and dose control. Fountain’s educational materials emphasize physician-guided care, individualized protocols, and treatment within a broader clinical framework rather than a one-size-fits-all model.

Intranasal esketamine

Esketamine nasal spray follows a different regulatory and clinical pathway, with FDA-approved labeling and REMS-related supervision requirements. That creates a different treatment architecture from IV care, even when both are being discussed in the context of depression-related treatment. Fountain’s own education page on this comparison highlights that the difference is not just the molecule but the delivery system and care environment.

Why patients should not assume one route is best for everyone

The right question is usually not, “Which type wins?” It is, “Which option, if any, fits my diagnosis, risk profile, treatment history, and care goals?” That is a safer, more clinically responsible frame for new patients.

What new patients in NYC should know before comparing ketamine options

If you are exploring ketamine care in NYC, start with the basics.

Evaluation comes first

A meaningful comparison starts with a real evaluation, not with a social media claim or a headline. A clinician should review symptoms, prior treatment history, current medications, medical factors, and whether ketamine-related care is a reasonable topic to explore at all. Fountain’s educational content consistently frames ketamine as something that should be evaluated thoughtfully, not casually.

Monitoring matters

New patients should understand that supervision requirements differ by product and setting. This includes the care environment, observation after treatment when required, and planning for how the patient will be supported afterward. FDA safety communications around esketamine and compounded ketamine underscore why careful oversight matters.

The molecule is not the whole story

Two clinics can use similar words and still offer very different patient experiences. Screening, physician involvement, dose planning, integration, and follow-up all affect care quality. That is why patients should compare the clinical model, not just the drug name.

NYC context matters

In a city like New York, people are often balancing work, family, commute, privacy, and continuity of care. Practical questions matter: Who is supervising treatment? How is the patient prepared? How is follow-up handled? How personalized is the plan? Those factors often influence the real patient experience more than a headline comparison between isomers.

How Fountain Health NYC approaches ketamine care

At Fountain Health, ketamine care is framed as a physician-led process that includes screening, monitoring, and structured follow-up rather than a standalone product. Across the site’s educational materials, Fountain highlights structured clinical planning rather than generic treatment marketing. The practice describes a framework-based model for ketamine care and positions treatment as part of a broader biology-first mental health and wellness strategy.

For new patients, that can be a useful distinction. Even potentially powerful interventions require experience, screening, precision, and follow-up. Fountain’s materials also stress that ketamine is not for everyone and not a cure-all, which is the kind of framing patients should look for when evaluating providers.

Key terms that help patients understand ketamine care

Here are a few terms worth knowing as you compare options:

Anxiety: A broad mental health term that may overlap with stress, panic, or trauma-related symptoms.
Ketamine IV Therapy: Physician-supervised ketamine delivered intravenously in a clinical setting.
Ketamine Infusion: A common term for IV administration over a monitored period.
Ketamine-Assisted Psychotherapy (KAP): A model that pairs ketamine treatment with psychotherapy support.
Esketamine (Spravato): The S-ketamine nasal spray product with specific FDA-approved psychiatric indications.
Risk vs. Benefit: A core medical decision-making concept.
Psychedelic-Assisted Therapy: A broader category that can overlap with ketamine discussions, though treatment models differ.

Frequently asked questions about the different types of ketamine

Is ketamine the same as esketamine?

No. Esketamine is the S-ketamine isomer and is available as the FDA-approved nasal spray SPRAVATO for certain psychiatric indications. Ketamine usually refers to the broader drug, often meaning racemic ketamine, which is not FDA-approved for psychiatric disorders.

What does racemic ketamine mean?

It means the medication contains both R-ketamine and S-ketamine in equal parts. That is different from using only one isomer, such as esketamine.

What is the difference between R-ketamine and S-ketamine?

They are related mirror-image forms of ketamine. Researchers study them separately because they may differ in pharmacology and clinical effects, but many questions remain under investigation.

Is Arketamine approved for depression?

Not as a standard FDA-approved psychiatric treatment in current routine care. It is better understood as an active research topic.

Which type of ketamine is FDA-approved for depression?

Esketamine nasal spray has FDA-approved psychiatric indications. Ketamine itself is not FDA-approved for psychiatric disorders.

Why do some ketamine-related treatments require observation after dosing?

Because risks such as sedation, dissociation, respiratory effects, and misuse concerns can require supervised administration and post-dose monitoring, especially with FDA-labeled esketamine care.

Is IV ketamine better than esketamine?

There is no responsible universal answer. The better question is which option, if any, is appropriate for a specific patient after evaluation. Regulatory status, route, supervision, access, history, and goals all matter.

Can the type of ketamine determine the whole treatment outcome?

Not by itself. The clinical model, screening, monitoring, route, follow-up, and integration into a broader treatment plan matter too.

When to seek guidance from a clinician

If you are comparing esketamine vs arketamine, S-ketamine vs R-ketamine, or trying to understand whether IV ketamine belongs in your care conversation, it helps to speak with a qualified clinician rather than relying on online shorthand.

A good consultation should help you understand:

What form is actually being discussed
whether it is FDA-approved for the condition in question
How it is administered
What monitoring is involved
how risk versus benefit is weighed
how it fits, or does not fit, into your broader treatment plan

If you want to learn how Fountain approaches that decision-making process, start with The Fountain Health 4-Phase Ketamine Therapy Framework or explore more of the Fountain ketamine library.

Final takeaway

The different types of ketamine are best understood as a combination of chemistry, route, regulation, and clinical context. Racemic ketamine, esketamine, and arketamine are related, but they do not occupy the same place in patient care. For new patients, the goal is not to memorize every molecule, but to understand how chemistry, regulation, delivery method, and clinical oversight shape real treatment decisions.

Educational note: This article is for informational purposes only and is not medical advice. Ketamine-related treatment decisions should be made with a licensed clinician after individualized evaluation, including a discussion of risks, benefits, alternatives, and appropriate monitoring.

Continue exploring ketamine therapy

###

About Fountain: Fountain Health NYC is the next-generation biology-first mental health and medical wellness center exploring the frontier between neuroscience, technology, and human consciousness; redefining what healing can look like in the 21st century.

Types of Ketamine Explained: Racemic Ketamine vs Esketamine vs Arketamine